Literature DB >> 237501

[Myocardial metabolism under intravenous infusion of glucagon (author's transl)].

R Jesse, K W Schneider, P Deeg.   

Abstract

In 7 healthy-hearted probands the arterial-coronary-venous oxygen difference for glucose, K+, lactate, pO2, pCO2 and pH during a glucagon infusion was determined and compared with the values before and 10 minutes after infusion. Contradictory to the unchanged myocardial lactate extraction and the positively or negatively influenced K+-uptake recorded in the literature, in this contingent there was a statistically significant myocardial lactate production and an unchanged potassium uptake. The respiratory quotient of the heart increased. These changes are regarded as the result of a direct hormonal influence on the myocardial metabolism and have nothing to do with the change of an aerobic into an anaerobic metabolic state.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 237501     DOI: 10.1007/bf01905621

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  8 in total

1.  MYOCARDIAL METABOLIC AND CONTRACTILE RESPONSE TO GLUCAGON AND EPINEPHRINE.

Authors:  T J REGAN; P H LEHAN; D H HENNEMAN; A BEHAR; H K HELLEMS
Journal:  J Lab Clin Med       Date:  1964-04

2.  Regulation of glycogenolysis in muscle. Effects of glucagon and anoxia on lactate production, glycogen content, and phosphorylase activity in the perfused isolated rat heart.

Authors:  M CORNBLATH; P J RANDLE; A PARMEGGIANI; H E MORGAN
Journal:  J Biol Chem       Date:  1963-05       Impact factor: 5.157

3.  Cardiovascular effects of glucagon in man.

Authors:  W W Parmley; G Glick; E H Sonnenblick
Journal:  N Engl J Med       Date:  1968-07-04       Impact factor: 91.245

4.  [Effect of glucagon on extracellular potassium concentration measurements in aorta, hepatic vein and coronary sinus in man].

Authors:  B Lüderitz; H Avenhaus; C D Seufert
Journal:  Klin Wochenschr       Date:  1971-12-15

5.  Effects of glucagon on myocardial metabolism in patients with and without coronary artery disease.

Authors:  M G Bourassa; J Eibar; L Campeau
Journal:  Circulation       Date:  1970-07       Impact factor: 29.690

6.  Hemodynamic effects of glucagon in patients with heart disease.

Authors:  J F Williams; R H Childress; J N Chip; J F Border
Journal:  Circulation       Date:  1969-01       Impact factor: 29.690

7.  Hemodynamic effects of glucagon in patients following prosthetic valve replacement.

Authors:  W W Parmley; J M Matloff; E H Sonnenblick
Journal:  Circulation       Date:  1969-05       Impact factor: 29.690

8.  Coronary vascular effects of glucagon in the isolated dog heart.

Authors:  T W Moir; W G Naylor
Journal:  Circ Res       Date:  1970-01       Impact factor: 17.367

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.